Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III

Increased serum selenium levels are associated with reduced risk of advanced liver fibrosis and all-cause mortality in NAFLD patients: National Health and Nutrition Examination Survey (NHANES) III

Introduction and objectives: Selenium supplementation has been shown to have therapeutic value in chronic liver disease. We aimed to investigate the association between serum selenium, severity of liver fibrosis, and mortality in patients with Nonalcoholic Fatty Liver Disease (NAFLD). Patients or ma...

Full description

Bibliographic Details
Main Authors: Mishal Reja, Michael Makar, Aayush Visaria, Daniel Marino, Vinod Rustgi
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Annals of Hepatology
Subjects:
NAFLD
Liver fibrosis
Selenium
Mortality
Online Access:http://www.sciencedirect.com/science/article/pii/S166526812030079X

Similar Items

Similar Items